Most importantly, we have identified crucial transcription factors participating in this process and demonstrated the regulation of TGF-β1 by HIF-1α in a high glucose depended manner. We also explored pharmaceutical compounds that exhibit potential therapeutic efficacy against peritoneal fibrosis. Here, TGFB1 is linked to Peritoneal Fibrosis.